Eli Lilly and Co/ US5324571083 /
21/05/2024 22:10:00 | Chg. +19.99 | Volume | Bid10:34:45 | Ask10:34:45 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
803.17USD | +2.55% | 4.33 mill. Turnover: 1.86 bill. |
803.21Bid Size: 100 | 805.00Ask Size: 100 | 763.34 bill.USD | 0.58% | 138.00 |
GlobeNewswire
16/05
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
16/05
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
13/05
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13/05
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
08/05
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
08/05
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
01/05
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
29/04
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
26/04
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
22/04
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire
22/04
TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...
GlobeNewswire
17/04
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
GlobeNewswire
15/04
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...